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The calcium-sensing receptor (CaSR) is activated by various
cations, cationic compounds, and amino acids. In the present
study we investigated the effect of glucose on CaSR in HEK293
cells stably expressing human CaSR (HEK-CaSR cells). When
glucose concentration in the buffer was raised from 3 to 25 mM,
a rapid elevation of cytoplasmic Ca2 concentration ([Ca2]c)
was observed. This elevation was immediate and transient and
was followed by a sustained decrease in [Ca2]c. The effect of
glucose was detected at a concentration of 4 mM and reached its
maximum at 5 mM. 3-O-Methylglucose, a non-metabolizable
analogue of glucose, reproduced the effect of glucose. Sucrose
also induced an elevation of [Ca2]c in HEK-CaSR cells. Simi-
larly, sucralose was nearly as effective as glucose in inducing
elevation of [Ca2]c. Glucose was not able to increase [Ca2]c in
the absence of extracellular Ca2. The effect of glucose on
[Ca2]c was inhibited by NPS-2143, an allosteric inhibitor of
CaSR. In addition, NPS-2143 also inhibited the [Ca2]c re-
sponses to sucralose and sucrose. Glucose as well as sucralose
decreased cytoplasmic cAMPconcentration inHEK-CaSR cells.
The reduction of cAMP induced by glucose was blocked by per-
tussis toxin. Likewise, sucralose reduced [cAMP]c. Finally, glu-
cose increased [Ca2]c in PT-r parathyroid cells and in Madin-
Darby canine kidney cells, both of which express endogenous
CaSR. These results indicate that glucose acts as a positive allos-
teric modulator of CaSR.
The calcium-sensing receptor (CaSR)2 was originally identi-
fied in parathyroid cells as a receptor that regulates secretion of
parathyroid hormone by sensing changes in the concentration
of extracellular calcium (1). Elevation of extracellular Ca2 is
detected by this receptor, and phospholipase C is activated
leading to elevation of cytoplasmic Ca2 concentration
([Ca2]c) (1). The molecular structure of CaSR was revealed by
the expression cloning of CaSR from the bovine parathyroid
gland (2). CaSR is a glycosylated protein with a molecular mass
of120 KDa and belongs to the family C of G protein-coupled
receptors (GPCRs). It has a large extracellular domain, namely
the Venus flytrap domain (VFTD), and like other members of
the family CGPCR, CaSR forms a dimer to exert its function. In
addition to parathyroid glands, CaSR is expressed in tissues
involved in the regulation of Ca2 homeostasis including kid-
ney, intestine, and bone. This receptor is also expressed in var-
ious other tissues and organs including neurons and glial cells
(3) and may modulate the function of these cells (3–5).
Although CaSR was identified as a receptor sensing extracellu-
lar Ca2, many studies revealed that CaSR is in fact activated by
a variety of ligands. Those include various cations such as
Mg2, Mn2, Sr2, Ni2, andGd3, amino acids, polypeptides,
aminoglycosides, and polyamines (4, 5). Among them, a princi-
pal agonist for CaSR is Ca2, which binds to a pocket in the
VFTD (6). Binding Ca2 to the binding pocket in the VFTD
may cause a conformational change in the receptor molecule,
which eventually activates trimeric G proteins, leading to acti-
vation of the effector molecules. Amino acids bind to an adja-
cent site in theVFTDand act as allosteric activators ofCaSR (4).
An interesting feature of CaSR is that various synthetic allos-
teric modulators bind to domains other than VFTD, especially
the transmembrane domain, and modulate the function of
CaSR in positive and negative manners. For example, calcimi-
metics bind to the transmembrane domain and stabilize the
receptor in the active form (5). Conversely, NPS-2143, an allos-
teric inhibitor of CaSR, binds to the transmembrane domain of
CaSR and may stabilize the inactive conformation of CaSR (7).
In addition to the above-mentioned agonists, CaSR is also acti-
vated by the bitter compound named denatonium (8).
We have been studying the cell-surface receptor activated by
glucose in pancreatic -cells and enteroendocrine cells (9–11).
During the course of study,we found that physiological concen-
trations of glucose activate CaSR expressed in HEK293 cells. In
the present study we characterized the effect of glucose and
other compounds presenting sweet taste on CaSR in HEK293
cells stably expressing human CaSR (HEK-CaSR cells). The
results indicate that glucose acts as an allosteric modulator of
CaSR.
Results
Effect of Ca2 on [Ca2]c in HEK-CaSR Cells—We estab-
lished HEK293 cells stably expressing human CaSR (hCaSR).
As shown in Fig. 1A, HEK-CaSR cells expressed a considerably
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high amount ofmRNA for hCaSR comparedwith that in paren-
tal HEK293 cells. Fig. 1B shows the protein expression of CaSR
in HEK-CaSR cells. As can been seen, CaSR was detected in
HEK-CaSR but not in HEK293 cells. Immunocytochemistry
revealed that a considerable amount of CaSR was expressed on
the cell surface of HEK-CaSR cells (Fig. 1C). We then moni-
tored changes in [Ca2]c in HEK-CaSR cells using fluo-8. In the
presence of 2.5 mM extracellular calcium, oscillation of [Ca2]c
was observed in 34.0  2.0% (mean  S.E., n  3) of the cells
examined (Fig. 1D). In the presence of 1.3 mM extracellular
calcium, oscillation of [Ca2]cwas observed in 16.2 1.0% (n
3) of the cells (Fig. 1E). The amplitude and frequency of the
peaks of [Ca2]c in the presence of 1.3mM extracellular calcium
were considerably lower compared with those in the presence
of 2.5 mM extracellular calcium. In the absence of extracellular
calcium, no oscillation of [Ca2]c was observed (Fig. 1F). Note
that oscillation of [Ca2]c was not observed in naïve HEK293
cells in the presence of 1.3 and 2.5 mM Ca2 (Fig. 1G). The
addition of cinacalcet, an allosteric activator of CaSR (12),
induced a large transient elevation of [Ca2]c in the presence of
1.3 mM extracellular calcium in HEK-CaSR cells (Fig. 1H). In
HEK293 cells, cinacalcet did not affect [Ca2]c (Fig. 1I).
Effect of Glucose on [Ca2]c in HEK-CaSR Cells—In the pres-
ence of 1.3 mM extracellular calcium, oscillation of [Ca2]cwas
observed in some cells. When ambient glucose concentration
was raised from 3 mM to 25 mM, an application of the high
concentration of glucose induced an immediate transient ele-
vation of [Ca2]c in 64.1  9.9% (n  8) of the cells examined
(Fig. 2A). The peak of [Ca2]c was followed by a sustained
decrease in [Ca2]c. The biphasic response of [Ca2]c was not
due to changes in osmolarity as 25mMN-methylglucamine and
mannitol did not affect [Ca2]c (data not shown). It is of note
that glucose did not affect [Ca2]c in parental HEK293 cells
(Fig. 2B). A lower concentration of glucose, for example 8 mM,
induced a similar pattern of changes in [Ca2]c in HEK-CaSR
cells, and the magnitude of the peak of [Ca2]c and the area
under the curve (AUC) of the peak were nearly identical com-
pared with those obtained in cells stimulated by 25 mM glucose
(Fig. 2C). Fig. 2D depicts the dose-response relationship for
glucose-induced elevation of [Ca2]c. At high concentrations of
glucose, [Ca2]c response was observed in 60–70% of the cells.
As depicted, 5.0 mM glucose induced [Ca2]c response in
almost all of the cells. It should be noted that to observe the
effect of glucose on [Ca2]c, ambient glucose should be kept at
a low concentration, for example 3mM. The effect of glucose on
[Ca2]cwas not observedwhen the ambient glucosewas kept at
5.5mM. This is probably because 5.5mM glucose induces nearly
maximal allosteric stimulation. Glucose-induced changes in
[Ca2]c were inhibited by U73122, a nonspecific inhibitor of
phospholipase C, and [Ca2]c response to 25 mM glucose was
observed in only 25% of the cells in the presence of 10 M
U73122 (13). An inactive analogue of U73122 was not effective.
In addition, YM-254890, an inhibitor of Gq (14), completely
inhibited glucose-evoked changes in [Ca2]c (Fig. 2E). Note
that in the presence of YM254890, basal oscillation of [Ca2]c
was not observed.We also examined the effect of glucose on the
activation of protein kinaseC (PKC). To this end, wemonitored
the translocation of MARCKS from the plasma membrane to
cytosol. As shown in Fig. 2F, the addition of glucose induced an
increase in MARCKS in the cytosol. We next determined
whether or not glucose modulated the sensitivity of CaSR to
Ca2. To this endwemeasured the response of CaSR toCa2 in
different ambient glucose concentrations. As shown in Fig. 2G,
glucose did not affect the sensitivity of CaSR to Ca2.
Elevation of [Ca2]c induced by glucose was dependent on
extracellular calcium; glucose did not induce a peak of [Ca2]c
in the absence of extracellular calcium (Fig. 3A). The effect of
glucose was independent of glucose metabolism as 3-O-meth-
ylglucose, a non-metabolizable glucose analogue, increased
[Ca2]c, as did glucose (Fig. 3B).We then examined the effect of
NPS-2143, an allosteric inhibitor of CaSR that blocks [Ca2]c
FIGURE 1. Effect of Ca2on [Ca2]c inHEK-CaSR cells.A, expression of CaSR
in HEK-CaSR Cells. mRNA for CaSR was measured by quantitative RT-PCR in
HEK-CaSR and parental HEK293 cells and expressed as relative to that of
GAPDH. Values are themean S.E. for 12measurements. *, p 0.0001 versus
HEK cells. B, protein expression of CaSR in HEK-CaSR cells. Cell lysates
obtained fromHEK293 andHEK-CaSR cells were separated by SDS-PAGE, and
immunoblotting was done by using anti-CaSR antibody. C, immunocyto-
chemistry of CaSR in HEK-CaSR cells. HEK293 (a) or HEK-CaSR (b) cells were
stainedwith anti-flag antibody (red).D, changes in [Ca2]c inHEK-CaSR cells in
the presence of 2.5 mM extracellular calcium. Results are representative of
three experiments. E, changes in [Ca2]c in HEK-CaSR cells in the presence of
1.3mM extracellular calcium. Results are representative of three experiments.
F, changes in [Ca2]c in HEK-CaSR cells in the absence of extracellular calcium.
Results are representative of four experiments. G, changes in [Ca2]c in
HEK293 cells in the presence of 2.5mM extracellular calcium.H, effect of cina-
calcet on [Ca2]c in HEK-CaSR cells. Cinacalcet (5M) was added as indicated.
I, effect of cinacalcet on [Ca2]c in HEK293 cells. Cinacalcet (5 M) was added
as indicated.
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responses to Ca2 and other allosteric agonists (7). In the pres-
ence of NPS-2143, [Ca2]c response to 25 mM glucose was
observed in 10% of the cells (Fig. 3C), and [Ca2]c response
was blunted in these responsive cells (Fig. 3D).When cells were
stimulated by 8 mM glucose in the presence of NPS-2143,
[Ca2]c response was blunted and was detected in 2% of the
cells (Fig. 3, C and E). NPS-2143 also inhibited translocation
of MARCKS induced by glucose (Fig. 3, F and G). The effect of
glucose on [Ca2]cwas not inhibited by lactisole, an inhibitor of
the sweet taste receptor subunit T1R3 (15) (Fig. 3H). In fact, the
peak of [Ca2]c induced by glucose was higher, and [Ca2]c
response was observed in nearly 90% of the cells. Therefore, the
[Ca2]c response to glucose was rather enhanced by lactisole.
We then examined the effect of Ca2 on [Ca2]c in the pres-
ence and absence of glucose. In the presence of 3 mM glucose,
elevation of extracellular calcium from 1.3 mM to 2.2 mM
resulted in a rapid elevation of [Ca2]c (Fig. 4A). After the peak
of [Ca2]c, [Ca2]c decreased gradually, and oscillatory eleva-
tion of [Ca2]c was observed in some cells. In the absence of
glucose, the addition of 2.2 mM calcium induced a rapid peak of
[Ca2]c, which was followed by oscillatory decay of [Ca2]c
(Fig. 4B). It is possible that removal of glucose affected the cel-
lular functions because of the lack of fuels. To rule this out we
performed the same experiments by adding glyceraldehyde
FIGURE2.Effectofglucoseon [Ca2]c inHEK-CaSRcells.A, effect of glucose
on [Ca2]c in HEK-CaSR cells. Glucose concentration in medium was raised
from3 to 25mM as indicated by the arrow. Results are representative of those
obtained in eight experiments. B, effect of 25 mM glucose on [Ca2]c in
HEK293 cells. Glucose concentration was raised from 3 to 25 mM in naive
HEK293 cells, and changes in [Ca2]c were monitored. Results are represen-
tative of two experiments. C, effect of 8 mM glucose on [Ca2]c in HEK-CaSR
cells. Glucose concentration was raised from 3 to 8 mM glucose. Results are
representative of five experiments. D, dose-response relationship for the
effect of glucose. Effects of various concentrations of glucosewere examined
as in B and C, and the percentages of those responsive to glucose cells were
counted. Values are the mean S.E. of five to eight experiments. E, effect of
YM254890 on glucose-induced changes in [Ca2]c. YM254890 (10 M) was
added 30 min before the addition of 25 mM glucose. Results are representa-
tive of three experiments. F, effect of glucose on the activity of PKC. HEK-CaSR
cells transfected with MARCKS-GFP were stimulated by 5 mM glucose.
Changes in the MARCKS-GFP fluorescence in the cytosol were monitored.
Results are representative of three experiments. G, effect of glucose on the
sensitivity of CaSR to Ca2. Extracellular Ca2 concentration was raised from
1.3 to 2.3, 3.2, or 5.6mM in the presence of 3 (●), 5 (E), and 8mM () glucose.
[Ca2]c responses were measured, and AUC of the first peak was calculated.
Values are the mean of five determinations.
FIGURE 3. Effect of glucose and 3-O-methylglucose on [Ca2]c in HEK-
CaSRcells.A, effect of glucoseon [Ca2]c in the absenceof extracellular Ca
2.
Glucose concentrationwas raised from 3 to 25mM in the absence of extracel-
lular Ca2, and changes in [Ca2]cweremonitored. Results are representative
of five experiments. B, effect of 3-O-methylglucose on [Ca2]c. 3-O-Methylg-
lucose (25 mM) was added, and changes in [Ca2]c were monitored. Results
are representative of three experiments.C, HEK-CaSR cellswerepreincubated
with or without 3 M NPS-2143 and then stimulated by either 8 or 25 mM
glucose. Changes in [Ca2]cweremonitored, and the numbers of responsive
cellswere counted. Values are themean S.E. for three experiments.D and E,
HEK-CaSR cells were preincubated with 3 M NPS-2143 and then stimulated
by 25mM (D) or 8mM (E) glucose. Changes in [Ca2]cweremonitored. Results
are representative of three experiments. F, HEK-CaSR cellswere stimulatedby
5 mM glucose in the presence of NPS-2143 (3 M), and translocation of
MARCKS was monitored. G, HEK-CaSR cells were stimulated by 5 mM glucose
in the presence and absence of NPS-2143 (3 M), and translocation of
MARCKSwasmonitored. The AUC from 0 to 8min was calculated. Results are
the mean S.E. for 12 experiments. H, effect of lactisole on glucose-induced
changes in [Ca2]c. Glucose (25 mM) was added in the presence of 1 mM
lactisole, which was added 30 min before the stimulation by glucose.
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instead of glucose. However, the results were essentially the
same. When cells were stimulated by 1.5 M cinacalcet in the
presence of 1.3 mM extracellular calcium and 3 mM glucose, a
large transient elevation of [Ca2]c was observed (Fig. 4C). In
the absence of glucose, cinacalcet induced a similar pattern of
changes in [Ca2]c and a subsequent decrease reaching [Ca2]c
levels lower than the basal ones (Fig. 4D).
Effect of SweetMolecules on [Ca2]c in HEK-CaSRCells—We
then examined the effect of variousmolecules presenting sweet
taste. As shown in Fig. 5A, sucrose induced a similar pattern of
changes in [Ca2]c as glucose. Sucrose induced an immediate
transient elevation of [Ca2]c, which was followed by a sus-
tained reduction of [Ca2]c. It should be noted that ambient
glucose concentration should be kept low, for example 3mM, to
observe the effect of sucrose. The effect of sucrose on [Ca2]c
was not observed in the presence of 5.5 mM glucose. Again, this
is perhaps due to nearly maximal activation of CaSR by 5.5 mM
glucose. Likewise, sucralose, an artificial sweetener, induced
similar changes in [Ca2]c in HEK-CaSR cells (Fig. 5B). Fig. 5C
demonstrates the dose-response relationship for [Ca2]c
responses induced by sucrose and sucralose. Both sucrose and
sucralose induced amaximal effect at a concentration of 10mM,
although a high percentage of cells were reactive even at 4 mM.
Acesulfame-K, an artificial sweetener, also induced a similar
pattern of changes in [Ca2]c (Fig. 5D). Likewise, glycyrrhizin, a
natural sweet compound, induced biphasic changes in [Ca2]c
in HEK-CaSR cells (Fig. 5E). The effect of sucralose on [Ca2]c
was inhibited by NPS-2143. In the presence of NPS-2143, only
2%of the cells responded to sucralose (Fig. 5F). In those respon-
sive cells, elevation of [Ca2]c was blunted (Fig. 5G). Similarly,
the effect of sucrose was also inhibited by NPS-2143 (data not
shown).
Effect of Glucose on [cAMP]c in HEK-CaSR Cells—We then
measured changes in [cAMP]c by using Flamindo2 (16). As
shown in Fig. 6A, an elevation of [cAMP]c by forskolin induced
a decrease in the fluorescence ratio of Flamindo2, indicating
that forskolin elevated [cAMP]c. As shown in Fig. 6B, the addi-
tion of 5 mM glucose induced an immediate and sustained
increase in the fluorescence, which indicates that glucose
induced a rapid and sustained decrease in [cAMP]c. The effect
of glucose was observed in almost all of the cells examined. Fig.
6C demonstrates the effect of cinacalcet, an allosteric activator
FIGURE 4. Effect of changes in ambient glucose concentration on CaSR
activated by Ca2 and cinacalcet. A, effect of Ca2 on CaSR in the presence
of glucose. Cellswere incubated inbuffer containing3mMglucose, andextra-
cellular Ca2was raised from1.3mM to 2.2mMas shownby the arrow. Results
are representative of three experiments. B, effect of Ca2 on CaSR in the
absenceofglucose. Cellswere incubated inbufferwithoutglucose for 15min,
Then extracellular Ca2 was raised from 1.3 mM to 2.2 mM. Results are repre-
sentative of three experiments.C, effect of cinacalcet onCaSR in the presence
of glucose. Cells were incubated in buffer containing 3 mM glucose and 1.3
mM Ca2. Cinacalcet (1.5M) was added as indicated. Results are representa-
tive of two experiments. D, effect of cinacalcet on CaSR in the absence of
glucose. Cells were incubated for 15 min in buffer containing 0 mM glucose
and 1.3 mM Ca2. Then 1.5 M cinacalcet was added as indicated. Results are
representative of two experiments.
FIGURE 5. Effect of sweetmolecules on [Ca2]c in HEK-CaSR cells. A, effect
of sucrose on [Ca2]c. Sucrose (40 mM) was added as indicated by the arrow,
and [Ca2]c was monitored. Results are representative of six experiments. B,
effect of sucralose on [Ca2]c. Sucralose (20mM) was added as indicated, and
changes in [Ca2]cweremonitored. Results are representative of three exper-
iments.C, dose-response relationship for sucrose- and sucralose-induced ele-
vation of [Ca2]c. Experiments were carried out as shown in A and B, and the
percentage of responsive cells was counted. Values are the mean  S.E. for
three to six experiments.●, sucrose;E, sucralose.D, effect of acesulfame-Kon
[Ca2]c. Acesulfame-K (20 mM) was added as indicated, and changes in
[Ca2]c were monitored. Results are representative of three experiments. E,
effect of glycyrrhizin on [Ca2]c. Glycyrrhizin (3 mM) was added as indicated,
and changes in [Ca2]c were monitored. Results are representative of three
experiments. F, HEK-CaSR cells were stimulated by 20 mM sucralose in the
presence and absence of 3 M NPS-2143, and changes in [Ca2]c were mon-
itored. The number of responsive cells was counted. Values are the mean
S.E. for three experiments. G, effect of NPS-2143 on sucralose-induced
changes in [Ca2]c. Sucralose (20 mM) was added in the presence of 3 M
NPS-2143, which was added 30 min before the stimulation by sucralose.
Results are representative of three experiments.
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of CaSR, on [cAMP]c. As can be seen, cinacalcet induced a sus-
tained decrease in [cAMP]c. Similarly, the addition of 10 mM
sucralose induced a rapid and sustained decrease in [cAMP]c
(Fig. 6D). The effect of glucose on [Ca2]c was inhibited by
NPS-2143 (Fig. 6, E and F). Note that, in HEK-CaSR cells pre-
treated with pertussis toxin (PTX), the effect of glucose on
[cAMP]c was inhibited (Fig. 6G).
Effect of Glucose on [Ca2]c in Cells Expressing Endogenous
CaSR—The above results indicate that glucose activates CaSR
in HEK293 cells expressing hCaSR. To examine whether glu-
cose is capable of activating endogenous CaSR, we examined
the effect of glucose on [Ca2]c in PT-r cells (17), a cell line
established from the rat parathyroid gland. As shown in Fig. 7A,
PT-r cells expressed a significant amount of CaSR. In these
cells, elevation of extracellular calcium from 1.3 mM to 2.2 mM
induced an oscillatory elevation of [Ca2]c (Fig. 7B). Similarly,
cinacalcet induced an oscillation of [Ca2]c in PT-r cells (Fig.
7C). As shown in Fig. 7D, elevation of glucose concentration
from 3 mM to 8 mM evoked an oscillatory elevation of [Ca2]c.
This type of [Ca2]c response to glucose was observed in 34.0
5.0% (n 3) of the cells examined.We also examined the effect
of higher concentrations of glucose. As shown in Fig. 7E, an
immediate and transient elevation of [Ca2]c was observed in
response to 12mMglucose, whichwas followed by oscillation of
[Ca2]c. As shown in Fig. 7F, 25 mM glucose induced an imme-
diate increase in [Ca2]c. The elevation of [Ca2]c was only
transient, and subsequently, a sustained reduction of [Ca2]c
FIGURE 6. Effect of glucose on [cAMP]c in HEK-CaSR cells. A, effect of fors-
kolin on [cAMP]c. Forskolin (10M) was added as indicated by the arrow, and
changes in [cAMP]c were measured. Note that Flamindo2 fluorescence
decreases when [cAMP]c is elevated. Results are representative of three
experiments. B, effect of glucose on [cAMP]c. The effects of 5 mM glucose on
[cAMP]c was measured in HEK-CaSR cells. Results are representative of three
experiments. C, effect of cinacalcet on [cAMP]c. Cinacalcet (5 M) was added
as indicated, and changes in [cAMP]cweremeasured. Results are representa-
tive of two experiments. D, effect of sucralose on [cAMP]c. Sucralose (10 mM)
was added as indicated, and changes in [cAMP]cweremonitored. Results are
representative of two experiments. E, HEK-CaSR cells were incubated for 30
min with 3 M NPS-2143 and then stimulated by 5 mM glucose. Changes in
[cAMP]c were monitored. Results are representative of three experiments. F,
experiments were done as in B and E, and the AUC from 0 to 5 min was
calculated. Values are themeanS.E. for threeexperiments. *,p0.01 versus
without NPS-2143. G, effect of glucose on [cAMP]c in pertussis toxin (PTX)-
treated HEK-CaSR cells. Cells were pretreatedwith 1g/ml pertussis toxin for
14 h and then stimulated by 5 mM glucose.
FIGURE 7. Effect of glucose on [Ca2]c in PT-r cells. A, expression of CaSR in
PT-r cells. mRNA for CaSR was measured in PT-r cells and HEK293 cells by
quantitative RT-PCR. Values are the mean S.E. for five experiments. *, p
0.05 versus HEK293 cells. B, effect of Ca2 on [Ca2]c. PT-r cells were stimu-
lated by 2.2 mM Ca2, and changes in [Ca2]c were measured. Results are
representative of two experiments.C, effect of cinacalcet on [Ca2]c. PT-r cells
were stimulated by 5 M cinacalcet, and changes in [Ca2]c were monitored.
Results are representative of two experiments. D–F, effect of glucose on
[Ca2]c. PT-r cellswere stimulatedby 8mM (D), 12mM (E), or 25mM (F) glucose,
and changes in [Ca2]c were measured. Results are representative of three
experiments. G, effect of NPS-2143 on glucose-induced changes in [Ca2]c.
PT-r cells were preincubatedwith 10MNPS-2143 and then stimulated by 12
mMglucose. Changes in [Ca2]cweremonitored. Results are representativeof
four experiments. H, experiments were performed as shown in G. The AUC
from 0 to 6 min was calculated. Values are the mean  S.E. for four experi-
ments. *, p 0.01 versuswithout NPS-2143.
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was observed. This type of [Ca2]c response was observed in
almost all of the cells examined. The effect of glucosewas inhib-
ited by NPS-2143 (Fig. 7G). Note that higher concentration of
NPS-2143 was needed to inhibit rat CaSR (Fig. 7H). We then
stimulated PT-r cells with an artificial sweetener, sucralose. As
shown in Fig. 8A, 10 mM sucralose induced an oscillatory ele-
vation of [Ca2]c in 76.0 3.6% (n 3) of the cells. At 20 mM,
sucralose induced an immediate but transient increase in
[Ca2]c, which was followed by the oscillation of [Ca2]c (Fig.
8B). This type of [Ca2]c response was observed in 38.0 4.6%
(n  3) of the cells. We then knocked down CaSR by using
siRNA in PT-r cells. In CaSR knockdown cells, mRNA level for
CaSR was 30% that in control cells. In these cells, the effect of
glucose was not observed (Fig. 8C).
We next examined the effect of glucose on [Ca2]c inMadin-
Darby canine kidney (MDCK) cells (18), a cell line derived from
renal tubular epithelial cells expressing CaSR. In these cells the
elevation of extracellular Ca2 from 1.3 mM to 2.2 mM induced
an oscillatory elevation of [Ca2]c (Fig. 9A). This type of
response was observed in 48.0 5.0% (n 3) of the cells. The
addition of cinacalcet induced an immediate and sustained ele-
vation of [Ca2]c in nearly all of the cells (Fig. 9B). As in PT-r
cells, elevation of glucose from 3 mM to 5 mM induced an oscil-
latory elevation of [Ca2]c in 49% (mean of two) ofMDCK cells
(Fig. 9C). When ambient glucose concentration was further
increased to 12mM, glucose induced an immediate elevation of
[Ca2]c, which was followed by an oscillatory elevation of
[Ca2]c in 72.2  4.2 (n  3) of the cells (Fig. 9D). NPS-2143
inhibited the effect of glucose in MDCK cells (Fig. 9, E and F).
As shown in Fig. 9G, 10 mM sucralose induced a similar oscil-
latory elevation of [Ca2]c as glucose. This type of elevation of
[Ca2]cwas observed in 44% (mean of two) of the cells.We then
knocked down CaSR in MDCK cells using siRNA. In knocked
down cells, the mRNA level of CaSR was 30% that of control
cells. Glucose-induced elevation of [Ca2]c was inhibited in
CaSR knockdown cells (Fig. 9H).
Discussion
In the present study we showed for the first time that glucose
allosterically modulated CaSR and increased [Ca2]c in HEK-
CaSR cells. The elevation of [Ca2]c was due to the allosteric
stimulation of CaSR by glucose as glucose did not affect [Ca2]c
in naive HEK293 cells. The effects of glucose on CaSR are
unique in several respects.
First, glucose exerts its effect at relatively low and physiolog-
ically relevant concentrations. In HEK-CaSR cells, an elevation
of [Ca2]cwas observed when ambient glucose was raised from
3 to 4 mM, and surprisingly 5 mM glucose elicited the maximal
effect. This implies that in physiological settings, CaSR is
already stimulated by the plasma glucose at least to some
extent.We have tomention thatmost of the previous studies to
FIGURE 8. Effect of sweetmolecules on [Ca2]c in PT-r cells.A and B, effects
of sucralose on [Ca2]c. PT-r cells were stimulated by 10 mM (A) or 20 mM (B)
sucralose, and changes in [Ca2]c were measured. Results are representative
of three experiments. C, CaSR knockdown PT-r cells were stimulated by 5mM
glucose, and changes in [Ca2]c were monitored. Results are representative
of three experiments.
FIGURE 9. Effect of glucose on [Ca2]c in MDCK Cells. A, effect of Ca
2 on
[Ca2]c in MDCK cells. Extracellular Ca
2 was raised from 1.3 mM to 2.2 mM,
and changes in [Ca2]c were monitored. Results are representative of three
experiments. B, effect of cinacalcet on [Ca2]c. Cells were stimulated by 5 M
cinacalcet, and changes in [Ca2]cweremeasured. Results are representative
of two experiments. C and D, effect of glucose on [Ca2]c in MDCK cells. Glu-
cose concentration in the buffer was raised from 3 mM to 5 mM (C) or 12 mM
(D), and changes in [Ca2]c were measured. Results are representative of
three experiments. E, effect of NPS-2143 on [Ca2]c. MDCK cells preincubated
for 30minwith 10MNPS-2143 and stimulatedby12mMglucose. Changes in
[Ca2]c were monitored. Results are representative of two experiments. F,
experiments were performed as shown in C and E. The AUC from 0 to 6 min
was calculated. Values are the mean  S.E. for 12 experiments. *, p  0.01
versuswithout NPS-2143.G, effect of sucralose on [Ca2]c in MDCK cells. Cells
were stimulated by 10mM sucralose, and changes in [Ca2]cweremeasured.
Results are representative of two experiments. H, CaSR knockdown MDCK
cells were stimulated by 12 mM glucose, and changes in [Ca2]c were moni-
tored. Results are representative of three experiments.
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characterize the function of CaSR in vitro were performed in
the buffer containing physiological concentration of glucose,
for example 5.5 mM glucose. This means that CaSR was already
stimulated significantly by the ambient glucose. In our experi-
ments, we characterized the function ofCaSR in the presence of
3.0 mM ambient glucose. Therefore, CaSR is less active in our
experimental conditions. Most of the natural agonists for CaSR
known to date are inorganic cations and organic cationic com-
pounds (5). In addition, aromatic amino acids such as Phe, Tyr,
His, and Trp act as positive allosteric modulators (19). Sugars
including glucose and sucrose as well as artificial sweeteners
should be considered as allosteric modulators of CaSR. Our
results are apparently different from those by Quinn et al. (20)
and Rogachevskaja (8). They showed that sucrose and sucrose
octaacetate did not affect [Ca2]c in HEK-CaSR cells. The
absence of the effect of these sugars may have been due to the
higher ambient glucose concentration. Although they did not
mention the exact concentration of glucose in the buffer used in
their measurements, it is likely that they used the buffer con-
taining 5.5 mM glucose. If so, CaSR was already activated by
glucose, and the effect of sucrose was difficult to detect.
Second, although glucose increased [Ca2]c in HEK-CaSR
cells in physiological conditions, glucose is not capable of acti-
vating CaSR in the absence of extracellular Ca2. In this regard
glucose is not a genuine agonist for CaSR, and instead, it acts as
an allostericmodulator of this receptor. In accordancewith this
notion, an allosteric inhibitor of CaSR, NPS-2143, inhibited the
effect of glucose on CaSR. This is in line with the observation
that NPS-2143 is able to inhibit the effect of Ca2 and calcimi-
metics such as NPS R-467 (21). Glucose and other sweet com-
pounds should be listed as allosteric modulators of CaSR.
Third, CaSR is activated not only by glucose but also by
sucrose and other natural and synthetic sweeteners, all of which
activate the sweet taste receptor (22). The effects of sucrose and
other sweeteners were due to activation of CaSR but not endog-
enous T1R3. This is deduced because these compounds were
ineffective in HEK293 cells. Furthermore, the expression of
T1R3 in HEK293 and HEK-CaSR was detectable by RT-PCR,
but the expression level was very low. Also, the effects of these
compounds were not inhibited by lactisole, an inhibitor of
T1R3 (12). In activating CaSR, however, these sweet taste com-
pounds are slightly less potent compared with glucose. This is
quite different from what we know about the activation of the
sweet taste receptor by these sweet compounds; sucralose and
sucrose are much more potent than glucose in activating the
sweet taste receptor (22). Although the rank of potency is dif-
ferent, these compounds resemble glucose in some respects in
activating CaSR. For example, these sweet molecules induced a
biphasic response of [Ca2]c; that is, an initial transient eleva-
tion of [Ca2]c followed by a sustained decrease in [Ca2]c. In
addition, as in the case of glucose, the effects of sucralose and
sucrose were inhibited by NPS-2143 (Fig. 4F). At present, the
exact binding site for glucose in CaSR is not certain. In this
regard, all these sweet taste molecules activate the sweet taste
receptor, a heterodimer of T1R2 and T1R3 (23), both of which
possess the VFTD. All these sweet compounds except glycyr-
rhizin bind to the VFTD of the sweet taste receptor subunit
(22). Given the similarity of the stereostructure of the VFTD
among members of the family C GPCR (24), it is possible that
glucose and sucrose interact with a site in VFTD of CaSR. This
possibility should be assessed experimentally in the near future.
Fourth, glucose-induced biphasic changes in [Ca2]c; a tran-
sient elevation was followed by a sustained decrease in [Ca2]c
(Fig. 2A). This is a rather unusual [Ca2]c response to Ca2
mobilizing agonists. At present, the mechanism for the sus-
tained reduction of [Ca2]c in response to glucose is not clear.
The sustained decrease in [Ca2]c may be explained by the
extrusion of Ca2 to endoplasmic reticulumor other organelles
together with suppression of Ca2 entry. The exactmechanism
for the unique action of glucose remains to be determined.
Fifth, glucose decreased [cAMP]c in HEK-CaSR cells (Fig.
5A). This response is mediated by the activation of Gi, as it was
blocked by the pretreatmentwith pertussis toxin. InHEK-CaSR
cells, cinacalcet also decreased [cAMP]c (Fig. 5C). As in para-
thyroid cells (25, 26), CaSR is coupled to Gi in HEK-CaSR cells.
The present results clearly show that CaSR is allosterically
stimulated by glucose at relatively low concentrations. The
physiological significance of this glucose effect, however, is not
certain at present. In this regard, the glucose sensitivity of CaSR
is quite high, and CaSR is already activated by physiological
concentrations of glucose in the plasma. Therefore, most of the
previous studies on CaSR performed in vitro and in vivo were
carried out under the conditions where CaSR is activated at
least to some extent by glucose. Recently, CaSR is shown to
function as the kokumi receptor in taste buds of the tongue (27).
CaSR is expressed in some population of the type 2 taste cells in
the taste buds (28).When stimulated by an agonist, for example
-glutamylcysteinylglycine (GSH), GSH activates the kokumi
pathway, which enhances the sweet, salty, and umami tastes
(27).When sweet substances such as sucrose are ingested, both
CaSR and the sweet taste receptor may be activated, and the
sweet sensation is enhanced by the activation of the kokumi
pathway.
We have been studying the cell-surface receptor activated by
glucose in pancreatic -cells (9, 11). In these cells, glucose acti-
vates cell-surface receptor, which is dependent on T1R3 (11).
Presumably, a homodimer of T1R3 may function as a glucose-
sensing receptor. Compared with the cell-surface receptor in
-cells, glucose sensitivity of CaSR is quite high. CaSR, which is
expressed considerably in -cells (29, 30), may be already acti-
vated in the presence of physiological concentrations of glu-
cose. There is a possibility that CaSR and T1R3 form a het-
erodimer. If this is the case, what is the glucose sensitivity of the
putative heterodimer? Does the heterodimer also function as
the glucose-sensing receptor? Further studies are clearly neces-
sary to address these issues.
In summary, CaSR is allosterically stimulated by physiologi-
cal concentrations of glucose in HEK-CaSR cells. This sugar
acts as an allosteric modulator of CaSR and elicits unique pat-
terns of intracellular signals.
Experimental Procedures
Materials—Sucralose, 3-O-methyl-D-glucose, and lactisole
were obtained from Sigma. Glucose, sucrose, acesulfame-K,
and glycyrrhizin were from Wako Pure Chemicals (Osaka,
Japan), and cinacalcet was from Chemscene LLC (Monmouth
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Junction, NJ). NPS-2143was kindly provided byDr. Yuzuru Eto
(Ajinomoto Co., Kawasaki, Japan). These chemicals were dis-
solved in a solution composed of 140mMNaCl, 5mMKCl, 1mM
MgCl2, 1.3mMCaCl2, 10mMHEPES/NaOH (pH7.3), and 3mM
glucose unless otherwise mentioned. This solution was named
extracellular solution (ECS) for descriptive purposes applied to
the experimental conditions. All of the chemical reagents used
to prepare the ECS were obtained fromWako Pure Chemicals
except HEPES (Dojindo Molecular Technologies, Kumamoto,
Japan).U73122, an inhibitor of phospholipaseC (PLC) (13), and
its inactive analogue U73343 were obtained from EDM Milli-
pore (Billerica, MA). YM25489, an inhibitor of Gq (14), was a
generous gift from Dr. Jun Takasaki (Yamanouchi Pharmaceu-
tical, Ibaraki, Japan).
Cell Culture—HEK293 cells obtained from the Riken Cell
Bank (Riken Bioresource Center, Ibaraki, Japan) were grown in
Dulbecco’s modified Eagle’s medium (DMEM) containing a
high concentration of glucose (Invitrogen), 10% fetal bovine
serum (FBS) (Sigma), MEMnon-essential amino acids solution
(Invitrogen), and penicillin-streptomycin solution (Wako Pure
Chemicals). HEK293 cells stably expressing hCaSR were con-
tinuously selected by adding G418 sulfate (Wako Pure Chemi-
cals) to the growth medium. PT-r cells (a rat parathyroid cell
line) (17) were grown in Epilife medium (Invitrogen) and anti-
biotics. MDCK cells (18) obtained from the American Type
Culture Collection were maintained in a “complete medium”
composed of -MEM (Invitrogen) supplemented with 10%
FBS, 2 mM L-glutamine (Invitrogen), and penicillin-streptomy-
cin solution. MDCK cells were grown to confluence in 35-mm
glass bottom culture dishes in -MEM. Cells were then washed
twice with minimum essential medium for suspension culture
(S-MEM, Invitrogen) and incubated in S-MEM supplemented
with 5% dialyzed fetal bovine serum, 2 mM L-glutamine, and
penicillin-streptomycin solution (low calcium medium). Cells
were incubated in low calcium medium for 16 h and then pre-
pared for the corresponding measurement. All of the afore-
mentioned cells were cultured in a humidified incubator with
95% air and 5%CO2 at 37 °C and kept in awarmed chamber that
maintained the extracellular solution in a temperature range
that oscillated between 35 °C and 38 °C during the experiment.
Establishment of HEK-CaSR Cells—Transfection was carried
out using an expression vector encoding hCaSR kindly pro-
vided by Dr. Edward Brown (Brigham and Women’s Hospital,
Boston, MA). Transfection was achieved using the Attractene
Transfection Reagent (Qiagen, Hilden, Germany) according to
the manufacturer’s protocol. hCaSR-transfected HEK293 cells
were selected using the functional expression of the neomycin
resistance gene included in the plasmid sequence for 14 days.
Sixty resistant colonieswere expanded, and their hCaSRmRNA
expression was evaluated by using real-time quantitative PCR
(31). Primers used in this study are shown in Table 1. Six colo-
nies expressing the highest amount of hCaSR mRNA were iso-
lated, and their [Ca2]c responses to different extracellular
conditions and various agonists were evaluated by using fluo-
rescence microscopy. The cell line with the strongest response
was used for all analyses.
Measurement of [Ca2]c and Activation of Protein Kinase C
in HEK-CaSR Cells—Two days before measurement, cells were
placed on 35-mmglass bottom culture dishes. ECSwas used for
the measurement of [Ca2]c. [Ca2]cwas monitored by using a
fluorescent Ca2 indicator fluo-8/AM (AAT Bioquest, Sunny-
vale, CA). HEK-CaSR cells were loaded with fluo-8 by incubat-
ing in ECS containing 4M fluo-8/AM for 30min on a hot plate
at 37 °C. For themeasurement, cells were placed inside a heated
chamber MI-IBC attached to the microscope stage and con-
nected to amicroscope objective lens heater through a temper-
ature controller (Olympus, Tokyo, Japan). The temperature of
the aqueous extracellular environment was tightly controlled
between 35 °C and 38 °C. Visualization was performed using an
UPlanApo 10/0.40 objective lens (Olympus). To detect the
fluorescence images, we used the AQUACOSMOS/ASHURA
imaging system (Hamamatsu Photonics, Hamamatsu, Japan)
(32). The values (F) were normalized to each initial value (F0),
and the relative fluorescence change was referred to as F/F0
(32). The stimulation was performed by slowly applying the
stimulus using a perfusion system inserted through a small
opening in the top of the warm chamber. For the analyses of the
effects of agonists and inhibitors, representative traces (each
one corresponding to one cell) were selected. Selected patterns
were considered representative when they showed a similar
reaction in 80% of all the examined cells in the observed
microscopic field. Four to seven representative traces are pre-
sented. For the determination of the dose-response relation-
ship, the sensitivity degree to a certain stimulus was estimated
by calculating the percentage of reactive cells and averaging the
results obtained from at least 10 samples corresponding to each
experimental protocol. Results are expressed as the mean 
S.E. of accumulated data obtained inmultiple experiments. Sta-
tistical analysis was performed using Student’s t test. To mon-
itor activation of PKC, we monitored translocation of a PKC
substrate myristoylated alanine-rich protein kinase C substrate
(MARCKS) (18). MARCKS is located in the plasma membrane
in a unphosphorylated state but is translocated to the cytosol
upon phosphorylation. Using cells transfected with EGFP-N2-
MARCKS, we monitored translocation of MARCKS from the
plasma membrane to the cytosol as described previously (33).
Measurement of Cytoplasmic [cAMP]c in HEK-CaSR Cells—
Changes in cytoplasmic cAMP ([cAMP]c) were monitored by
using Flamindo2 (16). HEK-CaSR cells were transiently trans-
fected with 1.2 g of plasmid encoding Flamindo2 using 4.5 l
of Attractene transfection reagent (Qiagen) per dish. Trans-
fected cells were cultured for 3 days at 30 °C. For imaging exper-
TABLE 1
Primers used this study
Forward Reverse
Human GAPDH 5	-GATCATCAGCAATGCCTCCT-3	 5	-TGTGGTCATGAGTCCTTCCA-3	
Human CaSR 5	-GCTCCTGTGCAGACATCAAG-3	 5	-AGGTGCCAGTTGATGATGGA-3	
Rat GAPDH 5	-TGCCACTCAGAAGACTGTGG-3	 5	-TTCAGCTCTGGGATGACCTT-3	
Rat CaSR 5	-GCCTCAGAAGAATGCCATGG-3	 5	-TCTGCACACTGTAGGGGAAG-3	
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iments, transfected cellswere incubated in ECS, and after extra-
cellular solution temperature reached the predetermined
values, cells were visualized using an UPlanApo 10/0.40
objective lens (Olympus). A 485-nm dichroic mirror (U-MGF-
PHQ fluorescence filter cube, Olympus) and an ORCA-3CCD
digital camera (Hamamatsu Photonics) containing an RGB
prism were used for the measurement of a single wavelength of
Flamindo2. Neutral density filters were not needed. For detec-
tion of the yellow fluorescence protein variant (citrine), we used
AQUACOSMOS/ASHURA imaging system (Hamamatsu Pho-
tonics). The values (F) were normalized to each initial value
(F0), and the relative fluorescence change was referred to as
F/F0. Stimulus was applied as described above. The analyses of
the reaction to each particular stimulus were processed, and
data were presented in the same way as described for the mea-
surement of [Ca2]c.
Immunoblotting—HEK293 and HEK-CaSR cells were washed
with phosphate-buffered saline (PBS) and lysed with PBS con-
taining complete Mini EDTA-free (Roche Diagnostics). Cell
lysates were cleared by centrifugation. Supernatants were
mixed with sample buffer (8 M urea, 5% SDS, 50 mM Tris/HCl
(pH 6.8), 0.343 M DTT, and 0.005% bromophenol blue) and
separated on 4–15% Mini-PROTEAN TGX Gel (Bio-Rad)
before transfer to Immobilon-P Membrane (Merck Millipore).
Membranes were blocked for 1 h at room temperature using
blocking buffer containing 5% skimmilk and 0.05% Polysorbate
20 (MP Biomedicals, LLC; Santa Ana, CA) in Tris-buffered
saline (TBS). Membranes were incubated with primary anti-
bodies, anti-calcium sensing receptor antibody (ab19347;
Abcam; Cambridge, UK) and anti--tubulin antibody
(ab11308; Abcam), at a 1:1000 dilution at room temperature for
2 h. Membranes were incubated with secondary antibody cou-
pled to horseradish peroxidase, anti-mouse IgG, HRP-linked
whole Ab sheep (NA931V; GE Healthcare) at a 1:1000 dilution
at room temperature for 1 h. Proteinwas visualized by luminate
(Merck Millipore).
Immunocytochemistry—HEK293 and HEK-CaSR cells were
washed with PBS, fixed with 3% paraformaldehyde at room
temperature for 40 min, washed with PBS, and blocked with
Block Ace (DS Pharma Biomedical Co., Ltd.; Osaka, Japan) at
room temperature for 40 min. Cells were incubated with pri-
mary antibodies and DYKDDDDK tag antibody (#2368; Cell
Signaling Technology, Inc; Danvers,MA) at a 1:1000 dilution at
room temperature for 1 h and washed with PBS. Cells were
incubated with secondary antibodies, goat anti-rabbit IgG
(HL) secondary antibody and Alexa Fluor 568 conjugate
(A-11036; Thermo Fisher; Waltham, MA), at a 1:1000 dilution
at room temperature for 1 h, after which the samples were
washed with PBS for 5 min twice and incubated with DAPI
(46190; Thermo Fisher) at a 1:1000 dilution at room tempera-
ture for 5min before they were mounted on the slide glass. The
cells were observed under a confocal laser scanningmicroscope
(FV1000; Olympus).
Knockdown of CaSR Using siRNA—MDCK and PT-r cells
were grown in 35-mm dishes until reaching80% confluence.
Then the cells were transfected with 1.2 g of CaSR siRNA
duplex for the dog gene (Sigma) or ON-TARGT plus SMART
pool siRNA for the rat gene (GE Healthcare). Transfection was
performed using Attractene reagent according to the manufa-
cturer’s instruction. After 24 h, the cells were tested in their
response to stimulants or prepared for measurement of mRNA
expression.
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